News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Neil D. Gross: Neoadjuvant immunotherapy for advanced, resectable cutaneous squamous cell carcinoma
Photo of Neil D. Gross from faculty.mdanderson.org
Sep 24, 2024, 11:40

Neil D. Gross: Neoadjuvant immunotherapy for advanced, resectable cutaneous squamous cell carcinoma

Neil D. Gross, The Director of Clinical Research in the Department of Head and Neck Surgery at MD Anderson Cancer Center, shared a post on X:

”Latest news on neoadjuvant immunotherapy for advanced, resectable cutaneous squamous cell carcinoma presented last week at the European Society for Medical Oncology 2024, showing durable improved survival at 29.4 months. MD Anderson Cancer Center is excited to launch HN014 NRG Oncology and TROG Cancer Research.”

Neil D. Gross

Source: Neil D. Gross/X

cancer Cancer research cutaneous squamous cell carcinoma ESMO24 European Society for Medical Oncology 2024 MD Anderson Cancer Center Neil D. Gross neoadjuvant immunotherapy OncoDaily Oncology skin cancer
Special Coverage
Blog
Dec 21, 2024, 19:42
Ruben Mesa: Over 200 research staff of Atrium Health Wake Forest Baptist trained on Just Ask Increasing Diversity in Cancer Clinical Trials
Blog
Dec 21, 2024, 19:39
Kyaw Thein: Investigational Treatments for Thyroid and Head and Neck Cancers
Blog
Dec 21, 2024, 19:25
Hesham ElGhazaly: From an academic institution into a globally recognized hub for healthcare, research and innovation
Blog
Dec 21, 2024, 19:21
Douglas Flora: The 19 Words I’m Learning to Embrace as a Leader in 2025
Blog
Dec 21, 2024, 19:19
Registration and abstract submission open for the PTCOG63 - SIOP Europe
Blog
Dec 21, 2024, 19:18
The Institute of Cancer Research's annual report for 2023-2024
Blog
Dec 21, 2024, 19:14
Pembrolizumab plus chemotherapy with or without bevacizumab for metastatic cervical cancer
Blog
Dec 21, 2024, 19:12
The International Cancer Control Partnership's latest global review of NCCPs is out now - NCI Center for Global Health
Blog
Dec 21, 2024, 18:59
Nominations for the SIOP Europe Lifetime Achievement are open
Blog
Dec 21, 2024, 18:57
Petra Ibum Adjah: Get your last self breast exams before the festivities begin
Blog
Dec 21, 2024, 18:54
Introducing Innovation at Your Fingertips - Total Health | Oncology
Insight
Dec 21, 2024, 18:46
Marengo Initiated Phase 2 Trial of Invikafusp Alfa for PD-1 Resistant Tumors, Expands to Europe